Maze Therapeutics, Inc.
MAZE
$13.31
-$0.18-1.33%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/19/2025
-
MarketBeat
8/17/2025
-
MarketBeat
8/17/2025
-
MarketBeat
8/17/2025
-
MarketBeat
8/16/2025
-
TipRanks Financial Blog
8/14/2025
-
MarketBeat
8/14/2025
-
Simply Wall St
8/12/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
The Fly
8/12/2025
-
Globe Newswire
8/8/2025
-
MarketBeat
8/7/2025
-
MarketBeat
8/6/2025
-
ETF Channel
8/6/2025
-
Ticker Report
8/6/2025
-
MarketBeat
8/5/2025
-
MarketBeat
8/3/2025
-
MarketBeat
7/31/2025
-
Simply Wall St
7/29/2025
-
Ticker Report
7/25/2025
-
MarketBeat
7/24/2025
-
MarketBeat
7/23/2025
-
MarketBeat
7/23/2025
-
Ticker Report
7/23/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Jan 5 and 9 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 850 5070
Address
171 Oyster Point Blvd
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and...
more